A straight answer before you spend
ChatGPT carries ads, but that does not mean an overseas clinic can advertise its treatments there. As of 8 October 2026, OpenAI’s health-services policy generally prohibits health-service ads outside the US and allows limited US advertising through individual review.
For a clinic serving international patients, that distinction belongs at the beginning of any proposal. Access to an advertising account is not permission to promote a particular service, in a particular country, on a particular placement.
If an agency offers “ChatGPT ads”, ask which service it means. It could be paid advertising inside ChatGPT, work to improve the clinic’s public information, or ordinary advertising made with AI tools. The label alone tells you very little.
This guide separates those activities and explains what to prepare. Its aim is to help your team make a sensible channel decision before committing budget, commissioning creative work or promising a new source of international inquiries.
How ads in AI assistants work
OpenAI’s advertising FAQ, checked on 8 October 2026, says its US ad test began on 9 February 2026. Eligible Free and Go users may see ads; Plus, Pro, Business, Enterprise and Edu accounts do not. Accounts identified as belonging to people under 18 are excluded.
The same FAQ describes sponsored placements below responses, visually separated from the answer. OpenAI says advertisers cannot shape, rank or alter ChatGPT’s responses. Buying an ad therefore does not buy an editorial recommendation.
Organic discovery is a separate workstream. Our guide to AI search for medical tourism clinics explains how to make public information accessible, specific and checkable. That work cannot secure a particular answer or citation.
The table below is a planning snapshot checked on 8 October 2026. It describes routes to advertising, not eligibility for every clinic.
| Platform | Position for healthcare | Buying route |
|---|---|---|
| ChatGPT | Restricted; see the US scope and review requirements below. | Ads Manager availability does not establish category permission. |
| Google AI Overviews | Distinguish ads around an overview from ads within it; healthcare is generally excluded within. | Existing eligible campaigns, under Google’s placement rules. |
| Google AI Mode | A limited US, English-language healthcare test has been reported. | Participating existing campaign formats; not a general healthcare launch. |
| Microsoft Copilot | Advertising exists; verify service, market and placement eligibility. | Existing Microsoft Advertising search assets. |
| Perplexity | Its retreat from advertising was reported in February 2026. | Do not make it a committed media-plan line without new confirmation. |
ChatGPT ads and health services: the rules
The decisive wording in OpenAI’s policy, updated 10 September 2026, is: “Ads for health services outside the US are generally prohibited.” Within the US, OpenAI may admit selected advertisers individually, including certain dental, hospital, diagnostic and minimally invasive cosmetic services.
The policy excludes unsafe medical products, products lacking required authorisation, unsupported treatment claims, experimental therapies, invasive or high-risk procedures, adult sexual-health services and products exploiting body-image concerns or other vulnerabilities. Licensure evidence may be requested. Review covers the advertiser, creative, destination and placement; approval is not simply a check of the headline.
Separately, OpenAI’s FAQ, checked on 8 October 2026, says ads are not placed near personal or mental health conversations. An advertiser’s eligibility does not make every potentially relevant conversation available.
For a clinic in Türkiye, the Gulf or Europe, our planning conclusion is to treat ChatGPT treatment advertising as unavailable unless OpenAI confirms the specific proposal. Targeting US users should not be treated as an automatic exception for treatment delivered elsewhere.
There has been a change to account availability. The current advertiser-country list, checked on 8 October 2026, includes Turkey, the United Arab Emirates and Saudi Arabia. Earlier lists excluding them are outdated. This is an account-access fact, not a relaxation of the health-services rule.
Before commissioning a campaign, write down the billing entity, treatment location, intended audience country, service and destination URL. Ask the agency to explain the applicable policy against that exact combination. Keep its answer with the proposal.
Do not disguise treatment promotion as travel or general wellness to get it through review. A proposal should describe the clinic’s actual offer transparently. If the required permission is absent, the useful decision is to redirect the budget and keep the preparatory work for a suitable channel.
Google’s AI ads: distinguish the placements
Google’s AI Overviews advertising guidance, checked on 8 October 2026, distinguishes ads above or below an overview from ads inside it. Placements around the overview are available across AI Overviews markets. Placements within it are available in English in 12 countries, with sensitive categories including healthcare generally excluded.
Existing eligible Search, Shopping and Performance Max campaigns can supply relevant placements. Google says advertisers cannot exclusively target or opt out of AI Overviews, and its reporting does not separately segment those ads; they are reported as top ads.
A separate development deserves careful wording. On 1 June 2026, Search Engine Roundtable reported Google Ads liaison Ginny Marvin’s confirmation of a small healthcare test in AI Mode for US English queries. Her comments also described eligible campaign formats across AI Mode and AI Overviews. That is evidence of a limited test, not worldwide access for medical tourism providers.
The Google healthcare and medicines policy, checked on 8 October 2026, remains relevant: restrictions vary by category and location, and some categories require Google certification. An AI placement does not remove those conditions.
If a proposal sells a standalone “AI Overview campaign”, ask what that means operationally. Which existing campaign will supply the ads? Which placements can the agency verify? What will its report actually separate? The answers should make the scope clear enough to compare with an ordinary search proposal.
For clinics already running eligible Google campaigns, start by reviewing the service pages, inquiries and operational results. A new placement name is not sufficient reason to change the offer, broaden the audience or increase spend before the team knows what is working.
Copilot and the rest
Microsoft’s July 2025 explanation, reviewed on 8 October 2026, says Copilot ads draw on existing search campaign assets. That provides a buying route, not blanket permission for clinics.
Check the Microsoft healthcare policy for the service and destination market, then confirm placement eligibility with Microsoft. Our review could not establish a universal Copilot rule covering international clinics. Microsoft’s published policy update also illustrates the category-specific restrictions: it announced a global exclusion for clinical-trial and experimental-treatment advertising from August 2023.
For Perplexity, the Financial Times reported on 18 February 2026 that it was stepping away from advertising over concerns about user trust. Treat that as a reason to seek fresh confirmation before allocating money, rather than assuming a continuing self-service ad channel.
Six things to prepare now
1. Build a clear, reviewable landing page
Identify the actual provider, treatment location and relevant clinicians. Describe the service accurately and make contact details easy to find. Connect each credential to its issuing body and remove unsupported claims. Altay’s Healthcare Websites service can help organise this information and the inquiry journey.
Review translated versions separately. An accurate English page does not resolve an exaggerated claim in another language.
2. Keep licence evidence organised
Maintain a current file of the business and clinical documents relevant to the advertised service. Record the holder, issuing body, scope and expiry date. Assign responsibility for renewals and for supplying documents through the platform’s designated process when requested.
Do not assume a group-level document covers every facility or clinician. Resolve naming differences before a reviewer has to ask.
3. Write factual ad copy
Build messages around the service, location, language support and a clear next step. Have clinical claims reviewed by an appropriately qualified person. Keep a record of the evidence supporting any statement that could affect a patient’s decision.
For example, “Speak with our international patient team about the assessment process” describes an action without promising a clinical outcome. Use it only where that service exists and the relevant advertising rules permit the offer.
4. Check inquiry capacity before increasing spend
Test an inquiry from each target language and time zone. Who sees it, who owns the response and who handles questions beyond the coordinator’s role? Set a realistic response standard and an escalation route.
Read the first reply as a prospective patient would. It should answer the practical question, identify the next step and explain how to provide necessary information through the clinic’s appropriate channel.
5. Measure qualified inquiries
Agree what a useful inquiry means before launch: a genuine request about an offered service that reaches the correct team and can proceed to an appropriate next step. Review response time, completed handovers and missed contacts alongside media spend.
Keep clinical assessment separate from marketing qualification. Do not send diagnoses, medical records or free-text patient messages into advertising or general analytics systems. Design reporting around the minimum non-sensitive information required.
6. Keep improving organic discovery
Work on the information patients can already find: service pages, clinician profiles and verifiable credentials. Use our AI search guide to structure the review.
Check availability and access in each priority market. Organic work is worthwhile where the relevant platforms support it, but it does not establish universal coverage or predictable mentions. It also gives the patient team clearer information to use in everyday conversations.
What to watch next
Review three items monthly: OpenAI’s policy changelog, its advertiser-country list, and Google’s AI advertising guidance, including developments in the reported healthcare test. Record what changed, the check date and whether it affects an actual planned campaign.
Recheck this article’s platform details in the week of publication and review the full post every three months. For an imminent campaign, verify eligibility again before launch. A proposal should carry its own dated policy assessment rather than relying on an old presentation or an undated screenshot.
Plan around what your clinic can use
Altay’s Digital Marketing service helps clinics plan campaigns around eligible channels, clear patient information and the capacity to handle inquiries. Start with the service and market you want to develop. We can then assess the channel options, landing pages and response process together, with a clear distinction between available placements, limited tests and opportunities that still need confirmation.